Archive: 25/04/2013
Are living liver donors at risk from life-threatening 'near-miss' events?
A study published in Liver Transplantation, a journal of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, reports that donor mortality is about 1 in 500 donors ...
Apr 25, 2013
Study confirms link between school climate and violence
School violence is a very important social issue world-wide. It poses a significant threat to the health, achievement, and well-being of students. Although the most highly published incidents involve serious physical violence, ...
Apr 25, 2013
Chemoresponse assay helps boost ovarian cancer survival
This spring, a team of researchers has released results from an eight-year study that shows improved survival rates for women diagnosed with ovarian cancer who undergo cancer tumor testing to determine the best treatment.
Apr 25, 2013
Patient centered medical home helps assess social health determinants and promote health
Physicians from the Departments of Pediatrics and Family Medicine at Boston Medical Center (BMC) and Boston University School of Medicine (BUSM) are proposing that current pediatric guidelines and practices could be implemented ...
Apr 25, 2013
Mayo Clinic creates institution-wide electronic prolonged QT interval warning system
Using a one-of-a-kind computer-aided program, Mayo Clinic has developed and implemented a Mayo-wide electronic warning system to identify patients at risk of QT-related deaths from an abnormality in the heart's electrical ...
Apr 25, 2013
Study reveals novel mechanism by which UVA contributes to photoaging of skin
A study conducted by researchers at Boston University School of Medicine (BUSM) provides new evidence that longwave ultraviolet light (UVA) induces a protein that could result in premature skin aging. The findings demonstrate ...
Apr 25, 2013
Research spinoff ReXceptor gets license for Alzheimer's treatment
Case Western Reserve's Technology Transfer Office has granted an exclusive license of a novel Alzheimer's Disease (AD) treatment strategy to spinoff company ReXceptor Inc., which plans to initiate early-stage human clinical ...
Apr 25, 2013